Xceleron names president and CEO
Colin Garner, founder of Xceleron is retiring from the president/CEO position and will now serve as the senior scientific advisor to Xceleron and a non-executive director. Mr Butler
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.